Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
5.42%
↑ 131% above average
Average (9y)
-17.45%
Historical baseline
Range
High:5.42%
Low:-41.06%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 5.42% | +364.1% |
| 2023 | -2.05% | +94.7% |
| 2022 | -38.59% | -20.6% |
| 2021 | -31.99% | -26.5% |
| 2020 | -25.29% | +38.4% |
| 2019 | -41.06% | -123.0% |
| 2018 | -18.42% | -45.6% |
| 2017 | -12.65% | -73.2% |
| 2016 | -7.30% | -185.7% |
| 2015 | -2.56% | - |